| James Mckay Suggs Iii, MD | |
|
1215 Lee St, Charlottesville, VA 22908-4202 | |
| (434) 924-2283 | |
| (434) 982-0019 |
| Full Name | James Mckay Suggs Iii |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Location | 1215 Lee St, Charlottesville, Virginia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1548796923 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 0101276443 (Virginia) | Primary |
| 207LP2900X | Anesthesiology - Pain Medicine | 0101276443 (Virginia) | Secondary |
| Entity Name | Baylor College Of Medicine |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881026664 PECOS PAC ID: 8022243971 Enrollment ID: O20131030000972 |
News Archive
An analysis of randomized trials indicates that compared with placebo, the magnitude of benefit of antidepressant medications varies with the severity of depressive symptoms, and may provide little benefit for patients with mild or moderate depression, but appear to provide substantial benefit for patients with very severe depression, according to an article in the January 6 issue of JAMA.
Researchers at the Johns Hopkins Bloomberg School of Public Health have for the first time identified the genetic mechanisms involved in the formation and survival of L-form bacteria. Their findings are described in a study published October 6 in the journal PLoS ONE.
Age limits on clinical trials need to be more flexible to allow more teenage cancer patients the chance to access new treatments, according to a report from the National Cancer Research Institute (NCRI), published in the Lancet Oncology.
"More money, less waste and smarter programmes are urgently needed to consolidate precious gains in the war on AIDS and HIV, UNAIDS said" in a report released on Thursday ahead of the disease's 30th anniversary and the beginning of the U.N. High Level Meeting on AIDS, Agence France-Presse reports.
Cellerant Therapeutics Inc., a biotechnology company developing novel hematopoietic stem cell-based cellular and antibody therapies for blood disorders and cancer, announced today that it has signed a contract valued at up to $153 million over five years with the Biomedical Advanced Research and Development Authority (BARDA) in the Office of the Assistant Secretary for Preparedness and Response of the Department of Health and Human Services, to develop CLT-008, a cellular therapy for the treatment of Acute Radiation Syndrome (ARS).
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| James Mckay Suggs Iii, MD Po Box 9007, Charlottesville, VA 22906-9007 Ph: () - | James Mckay Suggs Iii, MD 1215 Lee St, Charlottesville, VA 22908-4202 Ph: (434) 924-2283 |
News Archive
An analysis of randomized trials indicates that compared with placebo, the magnitude of benefit of antidepressant medications varies with the severity of depressive symptoms, and may provide little benefit for patients with mild or moderate depression, but appear to provide substantial benefit for patients with very severe depression, according to an article in the January 6 issue of JAMA.
Researchers at the Johns Hopkins Bloomberg School of Public Health have for the first time identified the genetic mechanisms involved in the formation and survival of L-form bacteria. Their findings are described in a study published October 6 in the journal PLoS ONE.
Age limits on clinical trials need to be more flexible to allow more teenage cancer patients the chance to access new treatments, according to a report from the National Cancer Research Institute (NCRI), published in the Lancet Oncology.
"More money, less waste and smarter programmes are urgently needed to consolidate precious gains in the war on AIDS and HIV, UNAIDS said" in a report released on Thursday ahead of the disease's 30th anniversary and the beginning of the U.N. High Level Meeting on AIDS, Agence France-Presse reports.
Cellerant Therapeutics Inc., a biotechnology company developing novel hematopoietic stem cell-based cellular and antibody therapies for blood disorders and cancer, announced today that it has signed a contract valued at up to $153 million over five years with the Biomedical Advanced Research and Development Authority (BARDA) in the Office of the Assistant Secretary for Preparedness and Response of the Department of Health and Human Services, to develop CLT-008, a cellular therapy for the treatment of Acute Radiation Syndrome (ARS).
› Verified 3 days ago
Farnaz M Gazoni, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1215 Lee St, Charlottesville, VA 22908 Phone: 434-924-2283 Fax: 434-982-0019 | |
Katherine T, Forkin, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1215 Lee St, Charlottesville, VA 22908 Phone: 434-924-2283 Fax: 434-982-0019 | |
Edward C. Nemergut, Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1215 Lee St, Charlottesville, VA 22908 Phone: 434-924-2283 Fax: 434-982-0019 | |
Allison J. Bechtel, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 1215 Lee St, Charlottesville, VA 22908 Phone: 434-924-2283 Fax: 434-982-0019 | |
Kristi Hackworth Rose, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2331 Seminole Ln Ste 201, Charlottesville, VA 22901 Phone: 434-293-4995 Fax: 434-971-3434 | |
Sunny S. Chiao, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1215 Lee St, Charlottesville, VA 22908 Phone: 434-924-2283 Fax: 434-982-0019 | |
Logan David Kinch, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 545 Ray C Hunt Dr Ste 316, Charlottesville, VA 22903 Phone: 434-243-5676 Fax: 434-243-5689 |